Back to top
more

DaVita (DVA)

(Delayed Data from NYSE)

$161.97 USD

161.97
575,208

+1.87 (1.17%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $161.95 -0.02 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 6% (16 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Revvity (RVTY) Launches New Molecular Testing for Newborns

Revvity's (RVTY) EONIS Q System is set to transform SMA and SCID testing, advancing global healthcare for infants.

Reasons to Add Intuitive Surgical (ISRG) to Your Portfolio Now

Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.

3 Reasons to Retain Inspire Medical (INSP) Stock for Now

Inspire Medical's (INSP) focus on R&D raises optimism about the stock.

Inari Medical's (NARI) PEERLESS II RCT to Boost Patient Outcome

Inari Medical's (NARI) latest announcement of first patient enrollment in PEERLESS II RCT is likely to aid in changing guidelines in treating intermediate-risk PE patients globally.

Zacks.com featured highlights DaVita, Brinker International, CNA Financial and Integer Holdings

DaVita, Brinker International, CNA Financial and Integer Holdings have been highlighted in this Screen of The Week article.

Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Patterson Companies (PDCO) Q2 Earnings Miss, EPS View Lowered

Patterson Companies' (PDCO) second-quarter fiscal 2024 results reflect improvement in Dental Consumable sales, which were offset by lower Dental Equipment sales. Animal health sales improve.

Vasundhara Sawalka headshot

4 Stocks Trading Near 52-Week High That Can Climb Further

Investors target stocks that have been on a bullish run lately. Stocks like DVA, EAT, CNA and ITGR that are seeing price strength have a high chance of carrying the momentum forward.

Reasons to Retain West Pharmaceutical (WST) in Your Portfolio

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.

Reasons to Retain The Cooper Companies (COO) in Your Portfolio

The Cooper Companies (COO) benefits from strength in its business segments. Its acquisitions are likely to drive the top line. A rise in selling, general and administrative expenses is concerning.

Philips (PHG) Bolsters Diagnostic Imaging With New Launches

Philips (PHG) unveils an array of AI-enabled innovations at RSNA23 to enhance diagnostic imaging capabilities across healthcare providers.

Urmimala Biswas headshot

5 Finest PEG-Based Value Stocks to Buy Now

Here are five stocks that match our screening criteria ¿¿¿ FOXA, DVA, LDOS, BLD and ITRI.

Here's Why Investors Should Retain Abbott (ABT) Stock Now

Investors are optimistic about Abbott (ABT) driven by expansion in the global market and raised guidance.

Haemonetics (HAE) Stock Up 4.2% YTD: Will the Rally Continue?

Investors are optimistic about Haemonetics (HAE), driven by a strategic focus on establishing leading positions in high-growth markets and raised guidance.

Cencora (COR) Hits 52-Week High: What's Aiding the Stock?

Investors are optimistic about Cencora's (COR) strength in the U.S. Healthcare Solutions business.

3 Reasons to Retain Ecolab (ECL) Stock in Your Portfolio

Ecolab's (ECL) strength in business raises optimism about the stock.

Haemonetics' (HAE) Plasma Growth, Innovation Aid Performance

Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.

Philips (PHG) Adds BlueSeal to its Diagnostic Imaging Portfolio

Philips (PHG) showcases BlueSeal MR Mobile to enhance diagnostic imaging capabilities across remote and rural communities.

Zacks Industry Outlook Highlights DaVita, Option Care Health, Addus HomeCare and Pennant

DaVita, Option Care Health, Addus HomeCare and Pennant have been highlighted in this Industry Outlook article.

Debanjana Dey headshot

4 Stocks to Watch in an Evolving Outpatient Home Health Industry

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, OPCH, ADUS and PNTG are well-poised to gain.

Reasons to Retain Cencora (COR) Stock in Your Portfolio for Now

Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

Cardinal Health (CAH) Gets FDA Warning for Monoject Syringes

The FDA is alerting healthcare providers and facilities against the use of Cardinal Health's (CAH) Monoject syringes with syringe pumps and PCS pumps.

Insulet (PODD) Up 31.5% Since Q3 Earnings: What's Driving It?

Insulet (PODD) continues to gain from the strong adoption of Ommipod 5 and market expansion.

DVA vs. CHE: Which Stock Is the Better Value Option?

DVA vs. CHE: Which Stock Is the Better Value Option?

Cardinal Health (CAH) Hits 52-Week High: What's Aiding It?

Investors are optimistic about Cardinal Health's (CAH) diversified product portfolio.